Latest debt-to-equity ratio
Eikon Therapeutics Debt-to-equity ratio
Direct answer
Eikon Therapeutics's debt-to-equity ratio is 54.07%.
The verified market snapshot reports 54.07%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Eikon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 54.07%